Medical News: ECTRIMS: 'Wow' Results for Oral Fumarate in MS - in Meeting Coverage, ECTRIMS from Med
www.medpagetoday.comAMSTERDAM -- Efficacy and safety data from a phase III trial of dimethyl fumarate (BG12) in relapsing-remitting multiple sclerosis were impressive enough to elicit a wow when they were shared with n
No comments:
Post a Comment